Air Liquide Presents a Project to Transform its Home Healthcare Activity in France
July 05 2023 - 12:30PM
Business Wire
Regulatory News:
On July 5, 2023, the management of Air Liquide Healthcare
(Paris:AI) presented a project to transform its Home Healthcare
activity in France to employee representatives. The project aims to
address the needs and expectations of patients and healthcare
professionals, and to adapt the activity’s business model to meet
the challenges of the healthcare system.
The aging of the population, combined with the increasing
prevalence of chronic illnesses and the desire of the vast majority
of French people to be able to stay at home for as long as
possible, place home healthcare (HHC) as an essential component
in the organization of the healthcare system. However, the
homecare model in France is threatened by a number of factors: the
continuing erosion of reimbursement levels, rising costs linked to
a regulatory framework which requires an obligation of means not
adapted to individual patient needs, the adoption of new, more
expensive, technologies and the acceleration of the inflationary
context since 2021.
Despite this context, Air Liquide continues to firmly believe in
this business and its professions. Since 1986, the Air Liquide
Group has made home healthcare one of its strategic priorities.
Today, with 1.9 million patients with chronic illnesses being cared
for at home, worldwide, Air Liquide's ambition is to support the
shift to homecare, and to provide more personalized attention
to the needs of patients and healthcare professionals, through
outcome-based care for patients, at the best possible cost to the
healthcare system.
As a key partner of the healthcare system, Air Liquide
intends to make a responsible contribution to its necessary
transformation by defining a new organizational model for its
Home Healthcare activities in France.
The transformation project presented to employee representatives
would involve reshaping the operational organization of one of
the Group's main homecare entities, Pharma Dom, simplifying its
brand portfolio, and regrouping some of its locations. It would
also aim to bring together certain cross-functional roles within a
single entity. A technology investment plan is part of this
transformation project, in order to optimize processes and
facilitate the day-to-day work of teams for patient care and their
exchanges with healthcare professionals.
Currently subject to consultation with employee representatives,
this project would lead to a reduction of 430 net positions. In
line with the Group's values, the plan would provide for the
implementation of appropriate measures to support all employees
concerned.
“Air Liquide Healthcare wants to propose new models of
homecare, enabling better organization of care pathways and quality
of life for patients, at the best possible cost to the healthcare
system. This indispensable transformation will be carried out in
consultation with our social partners. We will pay particular
attention to supporting our teams and maintaining a constructive
social dialogue”, explains Philippe Ogé, VP Home Healthcare
France.
About Air Liquide
Healthcare
Air Liquide Healthcare is a world leader
in medical gases, home healthcare services and specialty
ingredients. Our 16,400 employees support 1.9 Million chronic
patients at home, and supply medical gases solutions and associated
services for 15,000 hospitals and new places of care.
Leader of home healthcare in
Europe, we provide care for patients with chronic diseases such
as Chronic Obstructive Pulmonary Disease, sleep apnea, respiratory
failure, diabetes and Parkinson's disease. Thanks to our unrivaled
proximity with patients, we focus our efforts on improving what
really matters to them and aim to enhance their quality of life.
Relying on a unique combination of human and digital, we provide
personalized care, bringing the support each patient needs when he
needs it. In 2022, home healthcare activities represented more than
50% of Air Liquide's Healthcare revenue.
A world leader in gases, technologies and services for Industry
and Health, Air Liquide is present in 73 countries with
approximately 67,100 employees and serves more than 3.9 million
customers and patients. Oxygen, nitrogen and hydrogen are essential
small molecules for life, matter and energy. They embody Air
Liquide’s scientific territory and have been at the core of the
company’s activities since its creation in 1902.
Taking action today while preparing the future is at the heart
of Air Liquide’s strategy. With ADVANCE, its strategic plan for
2025, Air Liquide is targeting a global performance, combining
financial and extra-financial dimensions. Positioned on new
markets, the Group benefits from major assets such as its business
model combining resilience and strength, its ability to innovate
and its technological expertise. The Group develops solutions
contributing to climate and the energy transition—particularly with
hydrogen—and takes action to progress in areas of healthcare,
digital and high technologies.
Air Liquide’s revenue amounted to more than 29.9 billion euros
in 2022. Air Liquide is listed on the Euronext Paris stock exchange
(compartment A) and belongs to the CAC 40, CAC 40 ESG, EURO STOXX
50, FTSE4Good and DJSI Europe indexes.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230705388360/en/
Direction de la Communication media@airliquide.com
Relations Investisseurs IRTeam@airliquide.com
C3 AI (NYSE:AI)
Historical Stock Chart
From Jun 2024 to Jul 2024
C3 AI (NYSE:AI)
Historical Stock Chart
From Jul 2023 to Jul 2024